Product: | Cyclophosphamide Monohydrate | ||||||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number: | 17429 | ||||||||
CAS Number: | 6055-19-2 | ||||||||
Synonyms: | Cyclophosphamide monohydrate; Cytotoxan; 2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide | ||||||||
Pricing: |
| ||||||||
Formula: | C7H15Cl2N2O2P • H2O | ||||||||
Chemical Purity: | >97% | ||||||||
Molecular Weight: | 279.10 | ||||||||
Structure: | |||||||||
Appearance: | White crystalline | ||||||||
Category: | Anti-cancer compounds | ||||||||
Stability: | Stable under recommended storage conditions. | ||||||||
Storage: | Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature: 2-8°C. | ||||||||
Transportation: | IATA: Hazard Class: 6.1; UN Number: UN3464; Packing Group: III; Shipping Name: Organophosphorus compound, toxic, solid, n.o.s. (Cyclophosphamide monohydrate) | ||||||||
Literature References: | Cullion, K., et al., Targeting The Notch1 And MTOR Pathways In A Mouse T-ALL Model. Blood 113, 6172-81, (2009); Tammam, J., et al., Down-regulation Of The Notch Pathway Mediated By A Gamma-secretase Inhibitor Induces Anti-tumour Effects In Mouse Models Of T-cell Leukaemia. Br. J. Pharmacol. 158, 1183-95, (2009); Guerriero, J.L., et al., DNA Alkylating Therapy Induces Tumor Regression Through An HMGB1-Mediated Activation Of Innate Immunity. J. Immunol. 186, 3517-26, (2011); Gibson, L.F., et al., Regulation of BAX and BCL-2 expression in breast cancer cells by chemotherapy. Breast Cancer Res. Treat. 55, 107-117, (1999); Ren, S., et al., Inhibition of human aldehyde dehydrogenase 1 by the 4-hydroxycyclophosphamide degradation product acrolein. Drug Metab. Dispos. 27, 133-137, (1999); Inagawa, H., et al., Mechanisms by which chemotherapeutic agents augment the antitumor effects of tumor necrosis factor: involvement of the pattern shift of cytokines from Th2 to Th1 in tumor lesions. Anticancer Res. 18, 3957-3964, (1998); Merck 14,2747; Aldrich MSDS 1, 537:C / Corp MSDS 1 (1), 992:C / FT-IR 1 (1), 920:C / FT-IR 2 (1), 1582:D / FT-NMR 1 (1), 1500:B / IR-Spectra (3), 552:G / NMR-Reference 2 (2), 872:B / RegBook 1 (1), 1119:E / Sax 6, 1277 / Sigma FT-IR 1 (2), 418:D / Structure Index 1, 173:D:4 | ||||||||
MSDS: | Click here. | ||||||||
Description: | Cyclophosphamide is a cytotoxic nitrogen mustard derivative widely used in cancer chemotherapy. It cross-links DNA, causes strand breakage, and induces mutations. Its clinical activity is associated with a decrease in aldehyde dehydrogenase 1 (ALDH1) activity. |
Medica Lisotopes我们的专家将根据您的规格和项目需要准备您的标记和未标记标准的合成,中间体的合成,代谢物合成/表征,代谢物合成/表征等化合物。